• Home
  • Media
  • Press Releases

Press Releases

Gulf Pharmaceutical Industries Julphar announces Q3 2022 results.

Delivering sustained quarter over quarter growth during 2022 • Q3 2022 net sales from continuing operations of AED 415.7m • Q3 2022 EBITDA from continuing operations approaching AED 47.5m; The…

A Strategic Partnership to Establish the First Glargine Manufacturing Facility in the MENA Region in the UAE

UAE announces industrial deals worth AED 260m to manufacture medical equipment locally Abu Dhabi Medical Devices Company, PureHealth, Borouge, Julphar among companies signing MoU that will boost exports…

Julphar Announces Robust Q2 2022 Results Marking a Return to Profitability

Gulf Pharmaceutical Industries PSC (Julphar or the Company), one of the largest pharmaceutical manufacturers in the Middle East and Africa, today reports its financial results for the second quarter.…

Julphar and Huadong Medicine Announce Strategic Cooperation of Liraglutide in the Middle East and North Africa Market.

Gulf Pharmaceutical Industries PJSC Julphar and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Huadong Medicine Co, Ltd, announced strategic cooperation by which, Julphar…
This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, refer to our Cookie Policy.